Raynaud Disease: A Patient Guide
At a Glance
Raynaud disease causes temporary blood-vessel spasms that can turn fingers or toes white, blue, and red. Keeping the body warm often helps, while testing can identify secondary disease and medicines may improve circulation; severe pain or sores need urgent care.
Raynaud phenomenon is an umbrella term for an exaggerated vascular response to cold temperatures or emotional stress, where the small arteries in the fingers and toes (and sometimes the ears or nose) constrict so tightly that they temporarily block blood flow. This process, known as vasospasm, often follows a classic tricolor sequence: the skin turns white as blood flow is lost, blue as oxygen levels drop, and red as the vessels finally reopen and blood rushes back. While this reaction can be startling and uncomfortable, it is essentially a “misfire” of the body’s natural temperature-regulation system [1].
For the majority of people, this is an isolated, standalone condition known as primary Raynaud disease. It typically begins in the teenage years or early twenties, is more common in women, and while it may be life-long, it rarely leads to permanent tissue damage. However, for some, the spasms are a secondary symptom related to another condition, medicine, injury, or exposure (such as systemic sclerosis, lupus, or vibrating tools). Identifying whether the condition is primary or secondary is the central goal of a medical evaluation, as secondary Raynaud phenomenon may involve structural changes to the blood vessels that require careful long-term monitoring to prevent complications [2].
Doctors use specialized tools to distinguish between these two forms and determine an individual’s risk. Nailfold capillaroscopy, a non-invasive look at the tiny blood vessels at the base of the fingernail, allows clinicians to see if the vascular structure is healthy or showing signs of damage. This is often paired with autoantibody testing to check for immune system markers that might signal a broader health issue. These tests help create a personalized roadmap for care, shifting the focus from simple symptom management to the proactive protection of the vascular system [3][4].
Management usually begins with lifestyle adjustments focused on maintaining “core warmth” to prevent the body’s cold-defense reflex from triggering. When lifestyle changes are insufficient, medications like calcium channel blockers or PDE5 inhibitors are often prescribed to help keep blood vessels dilated and improve circulation. While most people live well with Raynaud’s, it is vital to recognize “red flags” such as new or non-healing sores, persistent intense pain, or sudden severe lack of blood flow. These signs of critical digital ischemia require urgent or emergency medical attention to restore blood flow and protect the health of the tissue [5][6].
Living with Raynaud’s means becoming an advocate for your own comfort and health. By understanding the biological triggers of your symptoms and working closely with a healthcare team to monitor for changes, you can effectively manage the condition. Whether your diagnosis is a benign lifelong companion or a signal of an underlying condition, the focus remains on empowering you to maintain your quality of life and protect your circulation through every season [7].
In this guide
6 chapters
Understanding Your Raynaud Diagnosis
Learn how doctors diagnose Raynaud phenomenon, distinguish primary from secondary forms, and use ANA testing and nailfold capillaroscopy to assess your risk.
The Diagnostic Process: What the Tests Tell You
Learn how Raynaud disease is diagnosed, including capillaroscopy, ANA and antibody testing, vascular checks, and signs of primary or secondary disease.
Causes and Triggers of Secondary Raynaud's
Learn what causes secondary Raynaud's phenomenon, including autoimmune disease, medications, smoking, frostbite, vibration exposure, and other possible triggers.
Managing Raynaud's: Lifestyle and Medications
Learn how to manage Raynaud's with warmth, trigger avoidance, smoking cessation, calcium channel blockers, PDE5 drugs, and medication safety when needed.
When Raynaud's Becomes Severe: Ulcers and Ischemia
Learn how severe Raynaud's can cause digital ulcers and ischemia, when symptoms need urgent care, and how IV prostanoids, bosentan, or surgery may help you.
Living With Raynaud's: Self-Care and Well-Being
Learn how to live well with Raynaud's using warming strategies, stress management, symptom monitoring, and guidance on when to report possible autoimmune signs.
Common questions in this guide
What is the difference between primary and secondary Raynaud disease?
How do doctors check whether Raynaud symptoms are secondary?
What can trigger a Raynaud attack?
How can I prevent or reduce Raynaud attacks?
What medicines are used when warming measures are not enough?
When are Raynaud symptoms an emergency?
What other symptoms should I mention if I have Raynaud phenomenon?
Get notified when new evidence is published on Raynaud disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Raynaud's phenomenon: new aspects of pathogenesis and the role of nailfold videocapillaroscopy.
Kuryliszyn-Moskal A, Kita J, Hryniewicz A
Reumatologia 2015; (53(2)):87-93 doi:10.5114/reum.2015.51508.
PMID: 27407233 - 2
Raynaud's Phenomenon: A Vascular Acrosyndrome That Requires Long-Term Care.
Klein-Weigel P, Sander O, Reinhold S, et al.
Deutsches Arzteblatt international 2021; (118(Forthcoming)).
PMID: 33632387 - 3
Recent advances in the workup and management of Raynaud phenomenon.
Lis-Święty A
Polish archives of internal medicine 2019; (129(11)):798-808 doi:10.20452/pamw.15008.
PMID: 31577265 - 4
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
Bellando-Randone S, Del Galdo F, Lepri G, et al.
The Lancet. Rheumatology 2021; (3(12)):e834-e843 doi:10.1016/S2665-9913(21)00244-7.
PMID: 38287630 - 5
Calcium channel blockers for primary and secondary Raynaud's phenomenon.
Rirash F, Tingey PC, Harding SE, et al.
The Cochrane database of systematic reviews 2017; (12()):CD000467 doi:10.1002/14651858.CD000467.pub2.
PMID: 29237099 - 6
Raynaud's phenomenon.
Haque A, Hughes M
Clinical medicine (London, England) 2020; (20(6)):580-587 doi:10.7861/clinmed.2020-0754.
PMID: 33199324 - 7
The role of capillaroscopy and thermography in the assessment and management of Raynaud's phenomenon.
Herrick AL, Murray A
Autoimmunity reviews 2018; (17(5)):465-472 doi:10.1016/j.autrev.2017.11.036.
PMID: 29526628
This page is for informational purposes only and does not constitute medical advice about Raynaud disease. A healthcare professional should evaluate new sores, severe pain, or sudden loss of blood flow.